Ignite Creation Date:
2024-05-05 @ 6:36 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00519506
Status:
COMPLETED
Last Update Posted:
2009-04-14
First Post:
2007-08-20
Brief Title:
A Phase II Study to Evaluate the Efficacy of ThromboView in the Detection of Pulmonary Emboli
Sponsor:
Agen Biomedical
Organization:
Agen Biomedical
Study Overview
Official Title:
A Phase II Study to Evaluate the Efficacy of Anti-Fibrin Humanized Monoclonal AntibodyDI-DD3B622-80B3 Fab Fragment ThromboView Conjugated With Technetium-99m in the Detection of Pulmonary Emboli
Status:
COMPLETED
Status Verified Date:
2009-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of the study is to determine the diagnostic accuracy of 99mTc ThromboView SPECT imaging for the detection of acute pulmonary embolism PE in patients for whom there is a moderate to high clinical suspicion for PE
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None